• Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51. https://doi.org/10.1093/neuonc/noab106. (The updated 2021 CNS WHO classification introduced a revised classification system for adult and pediatric-type gliomas.•)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ, et al. Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery. 2011;68(6):1548–54. https://doi.org/10.1227/NEU.0b013e318214a66e. (discussion 54-5).

Article  PubMed  Google Scholar 

Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, et al. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer. 2014;61(7):1173–9. https://doi.org/10.1002/pbc.24958.

Article  PubMed  PubMed Central  Google Scholar 

Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, et al. Pediatric low-grade gliomas: implications of the biologic era. Neuro Oncol. 2017;19(6):750–61. https://doi.org/10.1093/neuonc/now209.

Article  CAS  PubMed  Google Scholar 

Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118(5):1739–49. https://doi.org/10.1172/JCI33656.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet. 2013;45(6):602–12. https://doi.org/10.1038/ng.2611.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Ryall S, Zapotocky M, Fukuoka K, Nobre L, Guerreiro Stucklin A, Bennett J, et al. Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell. 2020;37(4):569-83.e5. https://doi.org/10.1016/j.ccell.2020.03.011. (International collaborative report representing the largest cohort of clinically and molecularly annotated cohort of pLGGs that sheds light on the pLGG molecular landscape and proposes a novel risk stratification system with the potential to improve prognostication and impact treatment.•)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG. Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape. J Clin Oncol. 2015;33(27):2986–98. https://doi.org/10.1200/JCO.2014.59.9217.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hwang EI, Kool M, Burger PC, Capper D, Chavez L, Brabetz S, et al. Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children’s Oncology Group Randomized ACNS0332 Trial. J Clin Oncol. 2018;36(34):JCO2017764720. https://doi.org/10.1200/JCO.2017.76.4720.

Article  PubMed  Google Scholar 

Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D, et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol. 2015;129(5):669–78. https://doi.org/10.1007/s00401-015-1405-4.

Article  CAS  PubMed  Google Scholar 

•• Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, et al. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol. 2019;20(7):1011–22. https://doi.org/10.1016/S1470-2045(19)30277-3. (First prospective phase II study consortium-based study demonstrating promising efficacy of MEK inhibition in recurrent/refractory pediatric low-grade gliomas with and without NF1. These results led the COG to launch 2 prospective randomized phase III clinical trials for patients with newly diagnosed pediatric low-grade gliomas comparing targeted therapy versus standard of care chemotherapy in patients with and without NF1.••)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacob K, Quang-Khuong D-A, Jones DTW, Witt H, Lambert S, Albrecht S, et al. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Clin Cancer Res. 2011;17(14):4650–60. https://doi.org/10.1158/1078-0432.Ccr-11-0127.

Article  CAS  PubMed  Google Scholar 

Bale TA, Rosenblum MK. The 2021 WHO classification of tumors of the central nervous system: an update on pediatric low-grade gliomas and glioneuronal tumors. Brain Pathology. 2022;32(4):e13060. https://doi.org/10.1111/bpa.13060.

Article  PubMed  PubMed Central  Google Scholar 

Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol. 1993;11(5):850–6. https://doi.org/10.1200/JCO.1993.11.5.850.

Article  CAS  PubMed  Google Scholar 

Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, et al. Pediatric low-grade gliomas: next biologically driven steps. Neuro Oncol. 2018;20(2):160–73. https://doi.org/10.1093/neuonc/nox141.

Article  CAS  PubMed  Google Scholar 

Giantini-Larsen AM, Pannullo S, Juthani RG. Challenges in the diagnosis and management of low-grade gliomas. World Neurosurg. 2022.

Youland RS, Khwaja SS, Schomas DA, Keating GF, Wetjen NM, Laack NN. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediatr Hematol Oncol. 2013;35(3):197–205. https://doi.org/10.1097/MPH.0b013e3182678bf8.

Article  PubMed  Google Scholar 

Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. J Child Neurol. 2009;24(11):1397–408. https://doi.org/10.1177/0883073809342005.

Article  PubMed  PubMed Central  Google Scholar 

Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children’s Research Hospital. J Clin Oncol. 1997;15(8):2792–9. https://doi.org/10.1200/JCO.1997.15.8.2792.

Article  CAS  PubMed  Google Scholar 

Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, et al. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008;51(2):245–50. https://doi.org/10.1002/pbc.21563.

Article  PubMed  Google Scholar 

Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M, et al. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol. 2007;25(6):682–9. https://doi.org/10.1200/jco.2006.06.8213.

Article  CAS  PubMed  Google Scholar 

Tovar-Spinoza Z, Choi H. MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives. Childs Nerv Syst. 2016;32(10):1947–56. https://doi.org/10.1007/s00381-016-3193-0.

Article  PubMed  Google Scholar 

Easwaran TP, Lion A, Vortmeyer AO, Kingery K, Bc M, Raskin JS. Seizure freedom from recurrent insular low-grade glioma following laser interstitial thermal therapy. Childs Nerv Syst. 2020;36(5):1055–9. https://doi.org/10.1007/s00381-019-04493-6.

Article  CAS  PubMed  Google Scholar 

Karajannis MA, Souweidane MM, Dunkel IJ. Letter to the Editor regarding clinical debate concerning treatment of pediatric LGG by Cooney et al. Neurooncol Pract. 2020;7(5):569–70. https://doi.org/10.1093/nop/npaa019.

Article  PubMed  PubMed Central  Google Scholar 

Revere KE, Katowitz WR, Katowitz JA, Rorke-Adams L, Fisher MJ, Liu GT. Childhood optic nerve glioma: vision loss due to biopsy. Ophthalmic Plast Reconstr Surg. 2017;33(3S Suppl 1):S107–9. https://doi.org/10.1097/IOP.0000000000000687.

Article  PubMed  Google Scholar 

Taveras JM, Mount LA, Wood EH. The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology. 1956;66(4):518–28. https://doi.org/10.1148/66.4.518.

Article  CAS  PubMed  Google Scholar 

Erkal HS, Serin M, Cakmak A. Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy. Radiother Oncol. 1997;45(1):11–5. https://doi.org/10.1016/s0167-8140(97)00102-3.

Article  CAS  PubMed  Google Scholar 

Cappelli C, Grill J, Raquin M, Pierre-Kahn A, Lellouch-Tubiana A, Terrier-Lacombe MJ, et al. Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child. 1998;79(4):334–8. https://doi.org/10.1136/adc.79.4.334.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr Blood Cancer. 2006;46(5):586–96. https://doi.org/10.1002/pbc.20655.

Article  PubMed  Google Scholar 

Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, et al. Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol. 2011;13(2):223–34. https://doi.org/10.1093/neuonc/noq178.

Article  PubMed  Google Scholar 

Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, et al. Outcomes of multidisciplinary management in pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2011;81(4):e481–8. https://doi.org/10.1016/j.ijrobp.2011.01.019.

Article  PubMed  Google Scholar 

Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, et al. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol. 2006;8(2):166–74. https://doi.org/10.1215/15228517-2005-011.

Article  PubMed  PubMed Central  Google Scholar 

Watson GA, Kadota RP, Wisoff JH. Multidisciplinary management of pediatric low-grade gliomas. Semin Radiat Oncol. 2001;11(2):152–62. https://doi.org/10.1053/srao.2001.21421.

Article  CAS  PubMed  Google Scholar 

Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg. 1995;82(4):536–47. https://doi.org/10.3171/jns.1995.82.4.0536.

Article  CAS  PubMed